Alpha 2.0
Login Register
» Articles » PMID: 35842461

Depth of Response and Progression-free Survival in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 2022 Jul 16
PMID 35842461
Authors
Audrey M Sigmund
Ying Huang
Amy S Ruppert
Kami Maddocks
Kerry A Rogers
Samantha Jaglowski
Seema A Bhat
Adam S Kittai
Michael R Grever
John C Byrd
Jennifer A Woyach
Affiliations
Soon will be listed here.
Citing Articles

Impacts of early therapy response, interval to therapy interruption, and cumulative therapy interruption duration on outcome of ibrutinib therapy in relapsed/refractory chronic lymphocytic leukemia.

Yang S, Li N, Zhu R, Feng Y, Zhuo J, Gale R Ann Hematol. 2023; 102(8):2181-2188.

PMID: 37393401 DOI: 10.1007/s00277-023-05309-z.